Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.248
-0.022 (-1.72%)
Mar 24, 2026, 10:27 AM EDT - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $4.16 million as of March 24, 2026. Its market cap has decreased by -62.85% in one year.
Market Cap
4.16M
Enterprise Value
275.10K
1-Year Change
-62.85%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $4.16M, a decrease of -97.20%. That is a compound annual growth rate of -51.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 3.97M | -33.85% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Azitra | 4.81M |
| Silo Pharma | 4.63M |
| Revelation Biosciences | 4.54M |
| Genprex | 4.43M |
| Aspire Biopharma Holdings | 4.37M |
| VivoSim Labs | 4.33M |
| Biodexa Pharmaceuticals | 4.24M |
| Aptevo Therapeutics | 4.20M |